Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

UK ‘in danger of falling behind the pack’ in cancer research, MPs told

The Health and Social Care Committee heard from specialists in cancer research.

The Independent UK

AI analysis could help speed up heart failure detection, research suggests

It is estimated that more than a million people in the UK are living with heart failure.

The Independent UK

The top 100 bosses in the U.K. scored a pay hike of over $600k last year—the highest in six years

Among the highest paid CEOs were pharmaceutical giant AstraZeneca’s chief Pascal Soriot, with £15.3 million ($19.6 million), and defense company BAE Systems CEO Charles Woodburn, who earned £10.7 million ($13.7 million).

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Top UK CEOs handed 16% pay rise as millions of workers squeezed – as it happened

Data from the High Pay Centre thinktank showed FTSE 100 bosses collected an average £500,000 pay rise last year, taking their median pay to £3.9m

The Guardian - UK

FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’

CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation

The Guardian - UK

FTSE 100 Live: Shares fade, NatWest profits after CEO exit, AstraZeneca rises

NatWest has reported a big jump in half-year profits to £3.6 billion, days after Alison Rose stepped down as chief executive.

Evening Standard

Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines

Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution

The Guardian - UK

Rishi Sunak to meet FTSE 100 bosses at new business council

Heads of 14 companies will meet prime minister to discuss how to attract more investment to the UK

The Guardian - UK

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

The Independent UK

‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

The Guardian - UK

Revealed: pharma giants pour millions of pounds into NHS to boost drug sales

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products

The Guardian - UK

AstraZeneca Plummets, Sacrificing A Breakout, On Mixed Results In Lung Cancer Treatment

AstraZeneca and Daiichi Sankyo reported mixed results Monday from a final-phase study of their lung cancer treatment, and AZN stock tumbled.

Investors Business Daily

AstraZeneca stock value falls by nearly £14bn after cancer drug trial results

Shares close down 8% on concerns that new lung cancer drug may not be as successful as hoped

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

AstraZeneca pledges to plant and maintain 200m trees globally by 2030

Drugmaker’s $4oom offsetting scheme aims to combat climate change and biodiversity loss caused by deforestation

Fortune

The U.S.'s top diplomat follows Elon Musk, Jamie Dimon, and Bill Gates to Beijing

Secretary of State Antony Blinken spent the weekend in China meeting top Chinese officials, including President Xi Jinping.

The Guardian - UK

AstraZeneca considers spinning off its China business

UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensions

Al Jazeera

Lung cancer pill cuts risk of death by half, study finds

The drug, developed by AstraZeneca, if taken daily after surgery, dramatically reduces risk of death, study shows.

Get all your
news in one place.

100’s of premium titles.
One news app.

Bangkok Post

AstraZeneca China boss pledges to ‘love the Communist Party’

BEIJING: The global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said on Friday.

The Walrus

The Vaccine Problem

To better weather future pandemics, the way countries procure vaccines needs to change radically

Investors Business Daily

Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns

Sanofi said Friday its shot significantly reduced the risk of babies becoming hospitalized with RSV. But Sanofi stock dipped Friday.

The Conversation

Air pollution is a hidden pandemic in Africa - tips on how to reduce your exposure and help combat it

Rapid urbanisation in Africa is worsening air pollution levels. There are economic as well as health consequences.

Investors Business Daily

AZN Stock Today: This Options Trade Boosts AstraZeneca Stock Yield To 21% Annualized

Selling the call option generates an income of 2.7% in just over one month.

Financial Times

How education became the new faultline in British politics

A growing number of voters are graduates and they are becoming less likely to back the Conservatives, threatening to redraw the country’s electoral map

The Guardian - UK

UK and Europe are falling behind US and China in biotech, says AstraZeneca boss

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.